Retatrutide is a specific, synthetic molecule engineered to activate three known hormone receptors: GLP-1, GIP, and glucagon
Foundayo is FDA-approved for: Weight loss in adults with obesity or overweight with at least one weight-related health condition (such as type 2 diabetes) One of the key differentiators for Foundayo is its administration: It is the only GLP-1 pill for weight loss that can be taken any time of day, with or without food
What a Medical Clinic Actually Charges in 2026 A search for tesamorelin cost in 2026 returns numbers that span an enormous range: $30 to $80 for a vial from research chemical sites, $200 to $400 per month from some telehealth platforms, and up to $1,500 monthly from premium concierge providers
Stacking MOTS-C During Off-Cycles MOTS-C pairs well with other peptides that don't overlap with its mechanism
The minimum acceptable standard for research-grade Retatrutide is 98% purity by independent HPLC analysis, with a batch-specific Certificate of Analysis